Research
Hormonal
The combination of an amylin analog and other anti-obesity peptide drugs has demonstrated higher clinical efficacy in reducing body weight than monotherapy.
Combination therapies may be more effective for weight loss than single-drug treatments.
StrongSupportsmedium confidence
The combination therapy is likely to be the first drug therapy where an amylin analog is used for obesity treatment.
Why this rating
Based on the review of clinical trials and research findings.
Source
A Review of Amylin Peptide Receptor Activators for Obesity Pharmacotherapy
Sang Min Lee · Current Drug Targets · 2025
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →